Background: Poststroke depression (PSD) is related to adverse functional and cognitive prognosis in stroke patients. The participation of kynurenine pathway metabolites in depression has been previously proposed; however, there are few studies on its role in PSD and disability in stroke.
Objective: To investigate if there is a correlation between serum kynurenines levels with poststroke anxiety and depression symptoms and disability scales.